Literature DB >> 33554537

Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.

Heike Weisser1, Katja Steinhagen2, Ralf Höcker1, Viola Borchardt-Lohölter2, Özlem Anvari3, Peter M Kern4.   

Abstract

OBJECTIVES: During the current pandemic, antibody testing based on venous serum helps to determine whether the tested person has been previously infected with SARS-CoV-2. Alternatively, capillary blood can be taken via a finger prick (dried blood spots, DBS). In this study, paired DBS and venipuncture samples were tested using two serological assays to evaluate the usability of DBS for the detection of anti-SARS-CoV-2 antibodies.
METHODS: Paired samples of DBS and venous serum were collected from 389 volunteers, of whom 75 had a recent PCR-confirmed SARS-CoV-2 infection, and tested for anti-SARS-CoV-2 IgG antibodies against both viral S1 and nucleocapsid protein (NCP) antigens using two ELISAs. Degree of agreement and correlation coefficients between ELISA results based on the two sampling methods were calculated.
RESULTS: Results of DBS showed almost perfect agreement and high correlations with results from corresponding serum samples in both the S1-based ELISA and the NCP-based ELISA.
CONCLUSIONS: ELISA results derived from DBS showed very high agreement to those obtained with serum, supposing adequate usability and robustness of DBS as sample material for detection of anti-SARS-CoV-2 antibodies. In the near future, large-scale epidemiological screening for antibodies against SARS-CoV-2 will be carried out. Since DBS reduce the strain on healthcare institutions regarding sample collection, they have a potential to facilitate efficient community- and population-based screening in the current SARS-CoV-2 pandemic.
© 2020 Heike Weisser et al., published by De Gruyter, Berlin/Boston.

Entities:  

Keywords:  COVID-19; ELISA; SARS-CoV-2; antibody detection; dried blood spots

Year:  2021        PMID: 33554537     DOI: 10.1515/cclm-2020-1436

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.

Authors:  Janneke D M Verberk; Marieke L A de Hoog; Ilse Westerhof; Sam van Goethem; Christine Lammens; Greet Ieven; Erwin de Bruin; Dirk Eggink; Julia A Bielicki; Samuel Coenen; Janko van Beek; Marc J M Bonten; Herman Goossens; Patricia C J L Bruijning-Verhagen
Journal:  Eur J Epidemiol       Date:  2022-05-28       Impact factor: 12.434

2.  Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against Receptor binding domain and full length spike protein of SARS-CoV-2.

Authors:  Gaurav Kwatra; Marta Nunes; Nisha Dhar; Vicky Baillie; Natali Serafin; Stephanie Jones; Shabir A Madhi
Journal:  J Virol Methods       Date:  2021-11-30       Impact factor: 2.014

3.  SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.

Authors:  Hannah L Itell; Haidyn Weight; Carolyn S Fish; Jennifer K Logue; Nicholas Franko; Caitlin R Wolf; Denise J McCulloch; Jared Galloway; Frederick A Matsen; Helen Y Chu; Julie Overbaugh
Journal:  Microbiol Spectr       Date:  2021-10-20

4.  Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection.

Authors:  Peyton K Miesse; Bradley B Collier; Russell P Grant
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

5.  Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection.

Authors:  Beth Catlett; Mitchell Starr; Dorothy A Machalek; Thidarat Danwilai; Michael Palmer; Andrew Kelly; John Kaldor; Gregory J Dore; David Darley; Gail Matthews; Philip H Cunningham
Journal:  J Clin Virol Plus       Date:  2022-06-24

6.  Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens.

Authors:  François Cholette; Rissa Fabia; Angela Harris; Hannah Ellis; Karla Cachero; Lukas Schroeder; Christine Mesa; Philip Lacap; Corey Arnold; Yannick Galipeau; Marc-André Langlois; Karen Colwill; Anne-Claude Gingras; Allison McGeer; Elizabeth Giles; Jacqueline Day; Carla Osiowy; Yves Durocher; Catherine Hankins; Bruce Mazer; Michael Drebot; John Kim
Journal:  Heliyon       Date:  2022-08-28

7.  Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots.

Authors:  Eline Meyers; Anja Coen; An De Sutter; Elizaveta Padalko; Steven Callens; Linos Vandekerckhove; Wojciech Witkowski; Stefan Heytens; Piet Cools
Journal:  J Clin Virol       Date:  2022-08-19       Impact factor: 14.481

8.  Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases.

Authors:  Joshua Zarbl; Ekaterina Eimer; Camilla Gigg; Gerlinde Bendzuck; Marianne Korinth; Corinna Elling-Audersch; Arnd Kleyer; David Simon; Sebastian Boeltz; Martin Krusche; Johanna Mucke; Felix Muehlensiepen; Nicolas Vuillerme; Gerhard Krönke; Georg Schett; Johannes Knitza
Journal:  RMD Open       Date:  2022-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.